<DOC>
	<DOCNO>NCT02274389</DOCNO>
	<brief_summary>The purpose study describe medical indication utilization expert medical consultation among participant treat bedaquiline ( BDQ ) , BDQ susceptibility base minimum inhibitory concentration ( MICs ) report baseline subsequent isolates , BDQ drug utilization data include dose , duration , past treatment history , past medical history , concomitant medication , health care site treatment , drug distribution mechanism use administration BDQ , patient outcome ( clinical microbiologic ) adverse event among BDQ-treated participant , include death .</brief_summary>
	<brief_title>A Prospective Patient Registry Patients Exposed Bedaquiline</brief_title>
	<detailed_description>This prospective ( observation population sufficient number person sufficient number year generate incidence mortality rate subsequent selection study group ) observational ( clinical study participant may receive diagnostic , therapeutic , types intervention , investigator assign participant specific intervention ) study participant treat BDQ . Participants enrol healthcare provider healthcare provider decide treat BDQ BDQ treatment initiation prior observation participant outcome . All participant meet inclusion criterion provide informed consent participation study enrol study . The registry enrollment period open 36 month additional 24 month BDQ treatment-free follow-up safety assessment last participant enrol 36 month enrollment period . Participants ' follow-up data collect visit healthcare provider course BDQ additional 24 month last BDQ dose participant lose follow-up . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<mesh_term>Bedaquiline</mesh_term>
	<mesh_term>Diarylquinolines</mesh_term>
	<criteria>Participants capable provide informed consent , must obtain prior collection patient outcomes document laboratory clinical variable meet study objective Participants document enrollment bedaquiline patient registry ( BPR ) prior start BDQ treatment document initiation BDQ treatment enrollment Participants document initiation BDQ treatment prior enrollment document patient outcomes documented laboratory clinical variable meet objective study No specific exclusion criterion apply study scenario follow inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pulmonary Multi-drug Resistant Tuberculosis</keyword>
	<keyword>Bedaquiline</keyword>
	<keyword>Sirturo</keyword>
	<keyword>Observational</keyword>
	<keyword>Prospective</keyword>
</DOC>